CXA’s disruptive tech redefines global health insurance industry, starting with Asia
CXA’s platform uses a data-driven approach to design employee-tailored benefits and wellness programmes and to learn what works
Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com
One Singaporean technology company’s response to Asia’s rising health care costs is disrupting the health and benefits industry – winning for itself industry awards, the support of the Singaporean government and Fortune 500 clients.
Launched in 2014, CXA is already valued at US$100 million. Its recent series B funding was led by Facebook co-founder Eduardo Saverin and the investment arm of Singapore’s Economic Development Board.
“Chronic disease is hitting Asia hard, with a rapidly ageing population that is susceptible to diabetes at an even lower body mass index than most of the West,” says Rosaline Chow Koo, founder and CEO. “Our Asia-built solution is tailored to Asia’s needs. It empowers employees to stay healthy and helps employers optimise their benefits spending by shifting the focus from treatment to prevention.”
CXA’s platform uses a data-driven approach to design employee-tailored benefits and wellness programmes and to learn what works. With data, employers can actually quantify the return on their benefits and wellness investments, and drive down their insurance premiums. The platform consolidates information about employees through a lifestyle questionnaire and biometric health screening results from labs.
Employees get recommendations on how to become healthy, rewards for improvements and the opportunity to convert one-size-fits-all insurance spending to personalised benefits from the platform’s online shop – from yoga and diabetes management to individual insurance.
CXA is expanding from Singapore and Hong Kong to the rest of Asia-Pacific. The company is also developing a tailored version for small and medium enterprises with the support of the Singaporean government.
“In five years, ours will be the new business model for the brokerage industry, not just in Singapore, but globally,” Koo says. “Insurers who are using our platform white-labelled in Asia are taking us to Europe and the United States.”